BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
19.05.26
/
50%
€42.92
Target price
19.05.27
€68.72
Performance (%)
20.69%
Price
10.07.26
€51.80
Summary
This prediction is currently active. The prediction currently has a performance of 20.69%. This prediction currently runs until 19.05.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.652% | -0.652% |
| iShares Core DAX® | -3.173% | 1.229% |
| iShares Nasdaq 100 | -1.006% | 0.381% |
| iShares Nikkei 225® | -3.600% | 1.005% |
| iShares S&P 500 | 0.214% | 2.924% |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $85.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-0.61%
10.07.26
10.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25